| INTRODUCTION
As one of the "most impressive" in the world, the UK's National Health Service (NHS) scores higher than counterparts in providing cost-effective care that is safe, efficient, effective, coordinated, and patient-centred. 1 The cost of UK health care is rising faster than inflation. 2 This is driven by an ageing population with more complex care needs, growing demand, and more expensive treatments. At the NHS' birth in 1948, the UK's average life expectancy was 69 years. 3 Despite its crucial role in extending this to 79 years, the NHS itself is in increasing danger of failing to survive the impressive benchmarks it has set for its people. 4 Notwithstanding a 2015/2016 budget of £116.4 billion, the NHS faces a growing dichotomy between demand and supply. 5 For example, while accident and emergency (A&E) attendances and hospital admissions over the past decade have risen 25% and 32%, respectively, real funding has risen only 10%. A growing flow problem also exists, with difficulty discharging patients increasingly attributable to fewer social care beds (26% of the problem at end 2014/2015 versus 30% at start 2015/2016). Consequently, a £2 billion deficit seems certain to rise. (1) These financial challenges fundamentally question the NHS' ability to continue meeting Bevan's core principles of free care at the point of use to all in need, while remaining taxpayer funded. The race for survival has begun, with NHS England's (2014) "Five Year Forward View" highlighting the time to attack the deficit is now. 6 Historical annual efficiency gains of 0.8% have improved in recent years to 2%-performance that must be maintained for the foreseeable future.
In trauma and orthopaedics (T&O), the desire to improve efficiency is recognised through the British Orthopaedic Association's "Getting it Right First Time" (GIRFT) report, which proposes improvements to care pathways, experience, and outcomes, ultimately intended to yield significant cost savings. 7 Potential targets for cost-efficiency interventions in the NHS are ubiquitous. Lord Carter recently found the price paid by NHS hospitals for hip replacement implants ranged from £788 to £1590, with average running costs of NHS hospitals ranging from £105 to £970 million per m 2 . 8 He concluded the potential for £5 billion in savings through reducing such cost variations alone. The principle of GIRFT is to reduce costs by encouraging standardisation, thereby minimising inequality and improving quality. Despite ongoing national debate into the merits (financial and clinical) of variations from GIRFT's strategy (for example, when considering cemented versus uncemented hip prosthesis), this approach is less controversial in other areas (for example, preventing infection).
Numerous studies of clinicians have revealed markedly limited awareness of the costs of the investigations and treatments they deliver. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] Most clinicians (around 80% in several series) are unaware of the costs of common medications. 19, 20 Clinicians generally lack formal cost education or easy access to cost data. A systematic review confirmed overall cost estimate accuracy was low, with fewer than 50% of clinicians' estimates accurate. 21 Doctors consistently overestimated the cost of inexpensive medications and underestimated the cost of expensive ones. 22 Frontline NHS doctors are key decision makers, empowered with the ability to influence care delivery costs.
The NHS Constitution (2012) outlines the shared rights and responsibilities of patients and professionals; through emphasising the importance of positive patient behaviours (like keeping appointments), this recognises the importance of a two-way value relationship. 31 With the NHS increasingly unsustainable, cost-containment is not an optional battle to balance care equality; there is already a 19-year difference between the UK regions with the highest and lowest average healthy life expectancy. 32 Clinicians and patients alike can make small changes count through behaviour-influencing "nudging" strategies to highlight the benefits of cost awareness and consequences of ignoring cost-effective, best practice. Individual or organisational cultural biases are usually responsible for resistance to change-even in the presence of compelling evidence. Highlighting the true cost of care to professionals and patients is rarely undertaken, usually only in the context of cuts. It is a fallacy to expect more efficient utilisation of health care resources and achieve sustainable efficiency and demand savings without educating all to the costs of care.
Increasing awareness of T&O care costs could influence decision-making among clinicians and patients, although the impact of this is unknown. Greater cost awareness has the potential to impact care quality, experience, and equality-both at the individual patient level, as well as for the wider patient population. This study therefore aims to explore the following:
1. Existing awareness of the costs of orthopaedic care among clinicians and health care providers.
2. Opinions on the impact of greater awareness of care costs on how clinicians and health care providers deliver care, and how their patients receive care.
3. Strategies for sustainable cost education.
2 | METHODS
| Literature search strategies
Literature searches were undertaken to review the evidence base around cost awareness among professionals and patients. The "PICO" tool was selected and used to develop the search strategy and identify suitable studies to address the study aims. 33 The search strategy is outlined in Figures 1 and 2 .
The overall paucity of evidence around the impact of cost education measures on health care was noted. 
| Data collection and analysis
Primary data will be collected through surveys of two stakeholders: patients and health care professionals. This follows the Delphi methodology to correlate and converge "expert" judgements to consensus-build on "what could or
should" be done in relation to cost education. 34 The surveys will be paper-based and administered in various areas of the T&O department of a single UK district general hospital over a two-week period to minimise inconvenience and maximise responses. Questions
will be primarily closed-ended to facilitate rapid completion and analysis, with free space for comments. Staff surveys will target all members of the multidisciplinary team allied to caring for patients in T&O. All patients present on the T&O wards and outpatient clinics during the survey window will be offered the opportunity to complete surveys.
Baseline cost data will be sourced from several sources, including NHS and UK governmental resources (for example, websites and reports), existing literature, as well as the Trust's procurement and finance departments.
Where multiple cost data sources are available, average values will be used.
Quantitative data will be analysed in Microsoft Excel (2016), with additional statistical analysis in IBM's SPSS (2015) to determine distribution and variability. Qualitative data will be presented both verbatim (direct quotes) and coded (for example, "agree" or "disagree").
| Ethics and local governance
This study will use publicly available data, anonymous feedback, and nonclinical information, so formal ethical approval will not be required. Surveys will seek to (a) ascertain existing knowledge and (b) obtain individual feedback and opinion. They will be retrospective (after provision of definitive care), anonymous, not influence future care, and clearly state their purpose as improving cost education. Feedback will be compared with known data and interpreted in the context of established best practice standards of candour, consent, and education. 35 Participation is voluntary, with verbal consent sought as per Royal College of Surgeons' (2015) consent guidance. 36 No identifiable data will be collected or stored, with responses anonymised and collated in an encrypted spreadsheet on a secure computer.
Original paperwork will be securely destroyed. 
| Patients
Patients' cost estimates are shown in Table 1 . These demonstrated marked variability from actual costs. Only four items were estimated to within 25% of actual cost. Estimates for the "total cost of broken hip treatment" demonstrated greatest absolute inaccuracy (£3787 underestimate). There were no significant differences between in and outpatients.
In 19 cases (86%), "expensive" items (costing >£200) were underestimated or "cheap" items (costing ≤£200) were overestimated by patients. Cost estimates of "cheap" items (eg, cannula and fluid bags) were relatively more inaccurate than "expensive" items (eg, hip or knee replacement surgery), despite the absolute error (in GBP £) being greater for the latter.
Patients' views on cost education are shown in Table 2 . Most (79%) reported inadequate cost awareness, with 75% at least "sometimes" wanting more cost information, and 71% stating this might change their use of health care.
The majority (83% and 67%, respectively) agreed educational measures would also curtail waste and improve NHS finances. However, the majority were uncertain whether greater cost transparency would translate to improved care quality. Nonetheless, 38% and 42%, respectively, felt either their individual or overall care experience could improve through better choices and reduced demand.
| Professionals
Professionals' cost estimates are shown in Table 3 . Only three items were estimated to within 25% of their actual cost.
Similar to patients, there was greater relative inaccuracy in estimates of "cheaper" items. In 18 cases (72%),
"expensive" items were underestimated or "cheap" items overestimated by professionals. Figure 4 shows a comparison of estimates between patients and professionals. Interestingly, there were no significant differences aside from "hourly rate-FY1 doctor" (P = .0298). "Hourly rate-physiotherapist" (P = .0516), "joint X-rays" (P = .0792), and "joint magnetic resonance imaging" (P = .0916) showed near-significant differences. Meaningful interprofessional comparisons were not possible due to low numbers.
Professionals' views on cost education are shown in Table 4 . Consistent with the literature, there was marked variability in the cost estimates of professionals, with both groups also overwhelmingly overestimating the cost of cheap items, and underestimating the cost of expensive items. 22 The views of professionals were broadly similar to those of patients. Most (89%) reported inadequate cost knowledge, 92% wanted to at least sometimes know more, and 90% suggested this might influence care delivery.
A similar majority (85% and 77%, respectively) also felt greater cost transparency could reduce waste and improve NHS finances.
As with patients, opinions regarding the impact on care quality and experience were mixed, with the majority unsure. However, 21% and 25% more, respectively, felt quality would improve for individuals and overall. Similarly, 11% more felt experience would improve.
| Limitations
Although a broad target audience was approached to ensure randomisation and minimise selection bias, validity of "opinion" data is a concern in single-site studies, as individual and local factors (outcome, perceptions, and service availability) may bias responses. 37 With surveys freely available, selection bias may have been introduced through only those with stronger opinions electing to respond.
| DISCUSSION
Frontline staff routinely observe the consequences of tightening budgets yet remain largely naïve to the costs of the care they provide. This study explored the impact of greater care cost awareness on the delivery and receipt of care.
The hypothesis-that most professionals and patients have limited awareness of care costs-was confirmed, and consistent with the literature. 19, 20 This is unsurprising given the widespread lack of cost education, with cost considerations in care decisions remaining taboo despite widespread media coverage of the NHS' struggles. There was also marked variability in cost awareness, with the cost of "expensive" items commonly underestimated, and "cheaper" items commonly overestimated. This variability restricts cost-efficiency and limits our ability to provide more equitable care.
A novel finding was most patients and professionals reporting that greater cost awareness might influence their approach to care decisions. Cost savings through "reduced waste" were a commonly highlighted benefit of greater cost awareness. It is unrealistic to specifically expect patients to request "cheaper" treatments were they to know the cost of the various options on offer. However, these findings suggest that patients may be more receptive to appreciating the need for cost-effectiveness based care decisions, particularly if they were better educated as to the underlying rationale. The hypothesis that "cost-ineffective" practices are usually the result of "cost-ignorance" was proven, with staff wanting to know more about care costs. 38 Differing experience and perspectives may lead to cost variations. Clinical leaders are increasingly challenged to make earlier decisions on newer, expensive treatments lacking a robust evidence base. 39 With 1 million patients treated every 36 hours, NHS patients are key stakeholders in patching up its fiscal leaks. With proven improvements in resource utilisation, the argument for improved cost education is strengthened. 40 Lack of standardisation in interventions often results from the idiosyncrasies of how patients present to services. For example, patients may be more inclined to visit their pharmacist for minor ailments were they to better understand that the resource savings could mean consequently greater accessibility to their GP or A&E when needed. 41 If players at each contact point are more cost aware, then their "little" differences could synergistically result in greater overall cost savings. Example cost savings gained through even a small reduction in demand in the outpatient setting are shown in Figure 5 . Both parties were cautious in predicting the impact of greater cost awareness on care quality or experience, although a greater proportion of professionals than patients felt this might confer a benefit. Educational interventions to improve cost transparency must remain mindful of patients' requests of caution in not compromising care quality, and ensuring care decisions are made, as one patient quoted, "on medical grounds, not financial."
Critics argue that absolute care costs correlate with neither quality nor outcomes. While some believe improvements in quality require investment (ie, cost increases), others argue that care quality improvements can in themselves lower costs (eg, through a reduction in complication rates or readmissions). As a result, the evidence base linking costs to quality is decidedly inconsistent. 42, 43 With life expectancy a proxy for overall health outcomes, this is noted to be generally higher in countries that spend more on health care; however, this is not always the case. For example, despite per capita health care spending in the United States of America (USA) being over double that of the UK (£6311 vs £2777), the USA has one of the lowest life expectancies among the ten Organisation for Economic Co-operation and Development countries. 44 Lack of cost-effectiveness, standardised clinical decision-making, and universal accessibility of care are all factors that play a role in this paradox; for example, rates of cardiac intervention following a myocardial infarction are five to ten times higher in the USA than Canada, despite overall outcomes being either similar or even better in Canada. 45, 46 It is this variability that interventions such as the UK's GIRFT initiative hope to address, using the NHS' might for more standardised and cost-effective procurement, thereby improving outcomes through focusing efforts at earlier stages of the patients' pathway and preventing the high cost of complications.
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Limited evidence suggests informing clinicians of the cost of tests has little influence on their ordering behaviour or the prices patients pay. 47 Patients in self-paying markets can either fail to obtain prescriptions or ration their medications due to high costs. 48 Conversely, publicising costs in a free NHS may promote a sense of "entitlement," with (15) 49% (23) Care quality (overall) 10% (4) 38% (18) 53% (25) Care experience (individual patients) 2% (1) 49% (23) 49% (23) Care experience (overall) 2% (1) 53% (25) 45% (21) Abbreviation: NHS, National Health Service.
patients demanding their tax-paid "money's worth." Small fines for missed appointments are oft proposed, supported by 61% of patients on a recent survey. 49 Alternatively, charging small fees for routine GP and A&E visits may highlight costs and redirect trivial problems, but would fundamentally undermine the NHS' philosophy, with only 16% of patients in favour of such a policy. However, as the NHS' finances diminish further, it is likely such policies will indeed be introduced by creep, so the time to act with any educational interventions to encourage greater cost-efficiency, is now. In our study, patients expressed a clear awareness of the state of the NHS' finances and the need for cost-containment ("saving money to spend on more doctors and nurses will benefit patient care"), but also highlighting their expectations, which undoubtedly place constraints on any educational strategy to encourage cost considerations within a universally free health care system ("if I need healthcare I should get it"). Such attitudes will undoubtedly impact the efficacy of cost education initiatives but should not detract from the underlying importance of encouraging even small cost improvements.
Whether professionals always want to know the costs of the care they deliver is unclear. In several small series', clinicians have reported feeling cost considerations in individual care decisions to be inappropriate or unethical, that they already limit investigation ordering to those clinically necessary, or that they do not want cost considerations to increase health care disparities or to prioritise the system above individuals. [50] [51] [52] With some claiming a lack of cost accountability on their part, the literature also reveals significant heterogeneity in clinicians' moral judgements and attitudes toward discussing treatment costs with patients. 53 However, the findings of other larger series' suggest that clinicians agree cost-containment is their responsibility, with cost-quality trade-offs relevant to decision-making given their wider economic benefits. 54, 55 Ensuring the NHS survives a future of austerity is ultimately crucial, with research from the USA suggesting one in ten adults have delayed or avoided getting care due to high costs. 56 To avoid the loss of universal health care in the UK, the case for cost-containment education is strengthened. However, while our cohort reported they might change their approach to accessing care were they to know the true cost, knowing the overall benefit or value of individual aspects of care (ie, cost-effectiveness or cost-utility) are perhaps of greater benefit to an individual patient or clinician when making care decisions. 57 To this end, encouraging education of more quality-adjusted metrics (such as the cost per quality-adjusted life year) may be of greater relevance to health care professionals when comparing care decisions, and to patients when explaining why certain treatments are no longer a priority for funding by their Clinical
Commissioning Group due to budget constraints. 58 Mismatch between clinician, provider and patient viewpoints can therefore result in miscommunication, poorly informed treatment decisions, and resistance from stakeholders in effecting interventions to increase cost-efficiency.
Education is key to aligning differences, and ensuring transparency on the issues contributing to rising health care costs. In a universally free NHS, costs are masked from patients and professionals, resulting in limited evidence for educational interventions. Yet with the annual cost of missed or unnecessary appointments estimated at £1 billion, significant sums could be saved by encouraging behavioural changes and greater health responsibility through educational measures, such as annual "health care statements." Highlighting costs and suggesting cheaper alternatives could reduce demand and improve cost-effectiveness of services. Recent novel approaches, such as "I-CARE" and "TARGET," use educational activities to stimulate cost discussions between clinicians, but impacts on decision-making and costs remain unclear. 59, 60 5 | CONCLUSION Health care is a truly unique industry. The challenge is to maximise the value the NHS adds for the individual and wider society. In an era of austerity, patients and clinicians alike must also become more accountable for ensuring effective and efficient use of resources. For example, Lord Carter (2016) identified £300 million annual savings through reducing national T&O infection rates, concluding "the provision of high quality care and good resource management go hand-in-hand." 18 However, finite resources mean the care an individual receives can influence the care of others. Our findings highlight the complex clinical, legal and ethical challenges that clinicians face when acting as "economic gatekeeper"-a situation increasingly the case in the UK with clinician-led Clinical Commissioning Groups now established-and may explain why clinicians chose to remain in the dark and "morally silent," despite acknowledging the benefits of more cost-effective decision-making. 61, 62 As clinicians increasingly wield the managerial reins for cost decisions, the distinct accountability that clinicians have for maintaining good clinical practice vs the manager's role of ensuring the books are balanced, becomes blurred. While cost awareness is important for all clinicians, being the sole gatekeeper for cost-control may potentially compromise the role of a clinician as the patient's advocate, increase wider inequalities in health care, and paradoxically increase costs due to delayed diagnosis through restricting access to specialists. 62 Nonetheless, to sustainably empower professionals and patients to challenge their own and others' behaviours, education is an inexpensive yet key weapon, and is certainly a good place to start when seeking cost-efficiency improvements. When demanding cost-efficiency, ignorance is costlier than education.
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